28688 Phase III Study of Lebrikizumab in Uncontrolled Asthma Patients

• Research type

  Research Study

• Full title

  A Phase III, Randomized, Double-Blind, Placebo Controlled Study To Assess The Efficacy and Safety of Lebrikizumab in Patients With Uncontrolled Asthma who are on Inhaled Corticosteroids and a Second Controller Medication.

• IRAS ID

  136007

• Contact name

  Brian Lipworth

• Contact email

  b.j.lipworth@dundee.ac.uk

• Sponsor organisation

  F. Hoffmann-La Roche Ltd

• Eudract number

  2013-000175-33

• Clinicaltrials.gov Identifier

  NCT01867125

• REC name

  West of Scotland REC 1

• REC reference

  13/WS/0248

• Date of REC Opinion

  11 Dec 2013

• REC opinion

  Further Information Favourable Opinion